Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
3.710
-0.150 (-3.89%)
At close: Jun 5, 2026, 4:00 PM EDT
3.800
+0.090 (2.43%)
After-hours: Jun 5, 2026, 7:57 PM EDT
Verastem Employees
Verastem had 102 employees as of December 31, 2025. The number of employees increased by 24 or 30.77% compared to the previous year.
Employees
102
Change (1Y)
24
Growth (1Y)
30.77%
Revenue / Employee
$486,127
Profits / Employee
-$1,901,559
Market Cap
326.01M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 102 | 24 | 30.77% |
| Dec 31, 2024 | 78 | 5 | 6.85% |
| Dec 31, 2023 | 73 | 16 | 28.07% |
| Dec 31, 2022 | 57 | 9 | 18.75% |
| Dec 31, 2021 | 48 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Abeona Therapeutics | 226 |
| Humacyte | 184 |
| Nautilus Biotechnology | 127 |
| Invivyd | 122 |
| Enanta Pharmaceuticals | 120 |
| Silence Therapeutics | 88 |
| Larimar Therapeutics | 71 |
| Atea Pharmaceuticals | 55 |
VSTM News
- 2 days ago - Verastem up 11% at $4.00 after announcing FDA Fast Track designation for VS-7375 - TheFly
- 2 days ago - Verastem announces FDA Fast Track designation for VS-7375 - TheFly
- 2 days ago - Verastem Oncology Announces U.S. FDA Fast Track Designation for VS-7375, an Oral and Potential Best-in-Class Investigational KRAS G12D (ON/OFF) Inhibitor for the Treatment of KRAS G12D-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer - Business Wire
- 2 days ago - Verastem Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 9 days ago - Verastem Oncology to Present at Jefferies Healthcare Conference - Business Wire
- 10 days ago - Verastem appoints Michael Bailey to board of directors - TheFly
- 10 days ago - Verastem Oncology Appoints Michael P. Bailey to its Board of Directors - Business Wire
- 16 days ago - Verastem Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts